Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221961 · ClinicalTrials.gov registry record
Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- 62
- Enrollment target
NCT01221961 is a clinical trial that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 62 participants.
The verdict
NCT01221961 was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- 62 participants
- Enrollment target
Study Summary
This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor); recorded several times throughout patient's major spine surgery procedure (depending on how many times the physician/nurse orders the Hb value to be tested), between the standard clinical practice {intermittent measure of Hb \[Cedar Sinai Medical Center (CSMC) Lab and outside lab) and Masimo radical-7 device (continuous, non-invasive Hb level measurements)\*.
Interventions
- DEVICE Masimo Radical-7
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2010-10 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01221961
The ClinicalTrials.gov registry entry for NCT01221961 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Masimo Radical-7 is the first listed.
NCT01221961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01221961 about?
NCT01221961 is a clinical study titled "Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery". This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor)...
What is the current status of trial NCT01221961?
This trial is currently terminated. The enrollment target is 62 participants. The study started on 2010-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01221961?
The interventions under investigation include: Masimo Radical-7 (DEVICE).
Who is sponsoring clinical trial NCT01221961?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.